RACHEL HARRIS: Open Payments
NPI 1447708060 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,597 in 127 payments from 16 companies in 2025. Trend: 2023 $1,208 · 2024 $1,940 · 2025 $2,597
Food & beverage: $2,597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $981 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $224 |
| Madrigal Pharmaceuticals | 9 | $223 |
| QOL Medical, LLC | 9 | $201 |
| Aimmune Therapeutics, Inc. | 10 | $178 |
| Janssen Biotech, Inc. | 8 | $176 |
| Ipsen Biopharmaceuticals, Inc | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Celltrion USA Inc. | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
Products named: RINVOQ, SKYRIZI, XIFAXAN, REZDIFFRA, Sucraid, ZENPEP, TREMFYA, MAVYRET.
Industry payments across TN — which companies pay providers there.
